MediWound (MDWD) Misses Q2 EPS by 3c

Go back to MediWound (MDWD) Misses Q2 EPS by 3c

MediWound Reports Second Quarter 2022 Financial Results and Provides Company Updates

August 9, 2022 7:30 AM EDT

Positive Results in Two Phase 2 Trials of EscharEx

FDA Assigned PDUFA Target Date of January 1, 2023 for NexoBrid BLA

Enhanced the Board and Leadership Team

Conference Call Begins Today at 8:30 AM Eastern Time

YAVNE, Israel, Aug. 09, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD), a fully... More